|

Zorifertinib and Osimertinib Combination Therapy Clinical Trials

1 actively recruiting trial

Also known as: AZD3759, AZD9291

Pipeline

Phase 1: 1

Top Sponsors

  • Alpha Biopharma (Jiangsu) Co., Ltd.1

Indications

  • Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression After Osimertinib Treatment1
  • Lung Cancer1
  • Cancer1

Other1 trial

Zorifertinib With Osimertinib for NSCLC With Meningeal Progression
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.